+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID05455307

Long-term Study of Self-Expanding Allium Ureteral Stents for Treating Difficult Ureteral Narrowing

Led by En Chu Kong Hospital · Updated on 2022-07-13

200

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective, multi-center study to observe the long-term safety and effectiveness of a self-expanding ureteral stent for treating people with refractory ureteral stricture. This condition involves persistent narrowing of the ureter that has not improved after at least two dilation procedures. The study aims to provide important insights into how well this ureteral stent works over time and its safety profile. Participants will receive the Allium ureteral stent, which is designed to expand and support the ureter, helping to relieve narrowing. This is a single-arm study without a placebo group, involving about 200 participants across four hospitals. After placement of the stent, the study will monitor kidney function, kidney ultrasound images, and any complications that arise. During the study, participants will have regular tests to evaluate kidney function and structure at intervals of 6, 12, 18, 24, 30, 36, 42, 48, 54, and 60 months. Researchers will also track any complications related to the stent over this five-year period. The study will help determine the long-term outcomes and safety of this treatment for refractory ureteral stricture.

CONDITIONS

Brief Title

Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture

Research Team

C

Chung Cheng Wang, MD PhD

H

Hsin-Yi Lin, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here